Trial Profile
A multicenter, randomized study of the sirolimus-eluting Bx Velocity balloon expandable stent vs. intravascular brachytherapy in the treatment of patients with in-stent restenotic coronary artery lesions.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia; Restenosis
- Focus Therapeutic Use
- Acronyms SISR
- Sponsors Cordis Corporation
- 13 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.